Immunosuppressive Medications (e.g., Cyclosporine, Methotrexate) Cost in Korea

Mijan Mijan • July 29, 2025

Immunosuppressive Medications (e.g., Cyclosporine, Methotrexate) Cost in Korea

Immunosuppressive medications like Cyclosporine and Methotrexate are often used in Korea to manage severe and refractory cases of chronic inflammatory skin diseases, including hidradenitis suppurativa and psoriasis. Korean dermatology and immunology specialists typically prescribe these medications under careful monitoring due to potential side effects, and treatment is tailored through regular blood tests and liver function evaluations. Korean hospitals and clinics emphasize safe dosage protocols and combination therapy for optimal results.

πŸ“Š Comprehensive Cost Overview

Medication Type Estimated Monthly Cost (KRW) Usage
Cyclosporine 150,000 – 300,000 For moderate to severe inflammatory conditions
Methotrexate 50,000 – 120,000 Weekly oral or injection-based therapy

πŸ” Detailed Cost Analysis by Component

Component Cost (KRW) Details
Initial Specialist Consultation 30,000 – 70,000 Required before starting immunotherapy
Cyclosporine Prescription (1 month) 150,000 – 300,000 Price varies by dosage and brand
Methotrexate Prescription (1 month) 50,000 – 120,000 Includes oral or injection form
Routine Blood Monitoring 30,000 – 70,000 Liver/kidney function and CBC tests

βž• Additional & Optional Services Cost

Service Cost (KRW) Description
Genetic Sensitivity Testing 100,000 – 200,000 Checks for metabolic reactions to drugs
Supplemental Folic Acid 10,000 – 20,000 Often used with methotrexate
Injection Administration Fee 10,000 – 30,000 If administered in-clinic

πŸ₯ Clinical Treatment Costs

Facility Type Cost Range (KRW) Includes
Dermatology Clinic 50,000 – 150,000 Consultation + monthly prescription
University Hospital 150,000 – 400,000+ Advanced monitoring and care plans
Immunology Specialist Centers 200,000 – 500,000+ Custom protocols, combination therapies
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
New paragraph
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025